As of 30 Sep 2025, 35 institutional investors reported holding 1,429,328 shares of NANOVIRICIDES, INC. - COM (NNVC).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1,429,328 | $2,043,864 | +$136,444 | $1.43 | 35 |
| 2025 Q2 | 1,335,364 | $1,869,101 | -$146,833 | $1.40 | 33 |
| 2025 Q1 | 1,485,768 | $1,736,822 | +$25,440 | $1.17 | 37 |
| 2024 Q4 | 1,457,742 | $2,085,592 | +$156,561 | $1.43 | 35 |
| 2024 Q3 | 1,340,466 | $2,011,241 | -$10,333 | $1.50 | 33 |
| 2024 Q2 | 1,343,393 | $2,310,168 | +$148,325 | $1.72 | 34 |
| 2024 Q1 | 59,713 | $67,902 | -$19,710 | $1.16 | 7 |
| 2023 Q4 | 1,208,815 | $1,232,256 | -$6,645 | $1.02 | 27 |
| 2023 Q3 | 1,203,566 | $1,612,348 | -$36,548 | $1.34 | 29 |
| 2023 Q2 | 1,234,492 | $1,419,105 | -$22,638 | $1.15 | 25 |
| 2023 Q1 | 1,252,853 | $1,467,525 | -$126,652 | $1.17 | 29 |
| 2022 Q4 | 1,361,712 | $1,509,858 | +$23,799 | $1.11 | 26 |
| 2022 Q3 | 1,325,768 | $2,292,000 | +$375,367 | $1.73 | 22 |
| 2022 Q2 | 1,109,563 | $2,084,000 | -$101,988 | $1.88 | 16 |
| 2022 Q1 | 1,163,910 | $2,435,000 | +$25,795 | $2.09 | 16 |
| 2021 Q4 | 1,105,711 | $4,111,876 | +$491,649 | $3.72 | 21 |
| 2021 Q3 | 954,175 | $4,425,037 | +$97,716 | $4.64 | 24 |
| 2021 Q2 | 905,353 | $4,200,037 | -$259,567 | $4.64 | 22 |
| 2021 Q1 | 988,648 | $4,663,578 | +$1,665,675 | $4.71 | 28 |
| 2020 Q4 | 645,820 | $1,852,023 | -$559,767 | $2.87 | 22 |
| 2020 Q3 | 779,429 | $2,991,031 | +$64,748 | $3.84 | 29 |
| 2020 Q2 | 758,287 | $5,672,289 | +$1,029,816 | $7.48 | 20 |
| 2020 Q1 | 647,401 | $3,714,733 | +$3,165,769 | $5.74 | 21 |
| 2019 Q4 | 139,902 | $351,130 | +$62,196 | $2.51 | 9 |
| 2019 Q3 | 119,953 | $245,188 | +$245,190 | $2.00 | 12 |